Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice

M. Sansone, V. Libri, F. Pavone, M. Ammassari-Teule

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The nootropic drug oxiracetam and the anticholinergic agent scopolamine were tested, alone or in combination, on shuttle-box avoidance acquisition and locomotor activity in mice of the CD-1 strain. Both drugs, given separately, slightly but significantly enhanced avoidance performance, but only scopolamine increased locomotor activity. Combinations of the 2 drugs, in some instances, enhanced avoidance performance more than drugs given separately, but the disinhibitory property of scopolamine makes it difficult to understand the role played by cholinergic mechanisms in these effects.

Original languageEnglish
Pages (from-to)208-216
Number of pages9
JournalArchives Internationales de Pharmacodynamie et de Therapie
Volume291
Issue number1
Publication statusPublished - 1988

Fingerprint

Scopolamine Hydrobromide
Locomotion
Nootropic Agents
Cholinergic Antagonists
Drug Combinations
Pharmaceutical Preparations
Cholinergic Agents
oxiracetam

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice. / Sansone, M.; Libri, V.; Pavone, F.; Ammassari-Teule, M.

In: Archives Internationales de Pharmacodynamie et de Therapie, Vol. 291, No. 1, 1988, p. 208-216.

Research output: Contribution to journalArticle

Sansone, M. ; Libri, V. ; Pavone, F. ; Ammassari-Teule, M. / Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice. In: Archives Internationales de Pharmacodynamie et de Therapie. 1988 ; Vol. 291, No. 1. pp. 208-216.
@article{c65f21bd4c9f4396947e4af4dc7d1dc5,
title = "Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice",
abstract = "The nootropic drug oxiracetam and the anticholinergic agent scopolamine were tested, alone or in combination, on shuttle-box avoidance acquisition and locomotor activity in mice of the CD-1 strain. Both drugs, given separately, slightly but significantly enhanced avoidance performance, but only scopolamine increased locomotor activity. Combinations of the 2 drugs, in some instances, enhanced avoidance performance more than drugs given separately, but the disinhibitory property of scopolamine makes it difficult to understand the role played by cholinergic mechanisms in these effects.",
author = "M. Sansone and V. Libri and F. Pavone and M. Ammassari-Teule",
year = "1988",
language = "English",
volume = "291",
pages = "208--216",
journal = "Archives Internationales de Pharmacodynamie et de Therapie",
issn = "0003-9780",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice

AU - Sansone, M.

AU - Libri, V.

AU - Pavone, F.

AU - Ammassari-Teule, M.

PY - 1988

Y1 - 1988

N2 - The nootropic drug oxiracetam and the anticholinergic agent scopolamine were tested, alone or in combination, on shuttle-box avoidance acquisition and locomotor activity in mice of the CD-1 strain. Both drugs, given separately, slightly but significantly enhanced avoidance performance, but only scopolamine increased locomotor activity. Combinations of the 2 drugs, in some instances, enhanced avoidance performance more than drugs given separately, but the disinhibitory property of scopolamine makes it difficult to understand the role played by cholinergic mechanisms in these effects.

AB - The nootropic drug oxiracetam and the anticholinergic agent scopolamine were tested, alone or in combination, on shuttle-box avoidance acquisition and locomotor activity in mice of the CD-1 strain. Both drugs, given separately, slightly but significantly enhanced avoidance performance, but only scopolamine increased locomotor activity. Combinations of the 2 drugs, in some instances, enhanced avoidance performance more than drugs given separately, but the disinhibitory property of scopolamine makes it difficult to understand the role played by cholinergic mechanisms in these effects.

UR - http://www.scopus.com/inward/record.url?scp=0023874180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023874180&partnerID=8YFLogxK

M3 - Article

VL - 291

SP - 208

EP - 216

JO - Archives Internationales de Pharmacodynamie et de Therapie

JF - Archives Internationales de Pharmacodynamie et de Therapie

SN - 0003-9780

IS - 1

ER -